{
  "zip": "V6C 3A6",
  "sector": "",
  "fullTimeEmployees": 5,
  "longBusinessSummary": "Pascal Biosciences Inc., a biopharmaceutical company, researches and develops products for the treatment of cancer, and for the enhancement of immune system. Its development portfolio includes PAS-403, a small molecule therapeutic advancing into clinical trials for the treatment of glioblastoma; and PAS-393, an immuno-stimulatory molecule to enhance the efficacy of checkpoint inhibitors. The company is also developing a B-cell targeted antibody for acute lymphoblastic leukemia and B cell lymphomas. The company has an exclusive license agreement with the University of Washington to develop a cannabinoid-based product for the treatment of glioblastoma multiforme and brain metastases; and a collaborative research agreement with SoRSE Technology Corporation to advance PAS-393 into clinical testing. Pascal Biosciences Inc. was founded in 2013 and is headquartered in Vancouver, Canada.",
  "city": "Vancouver",
  "phone": "604 880 7250",
  "state": "BC",
  "country": "Canada",
  "companyOfficers": [],
  "website": "http://www.pascalbiosciences.com",
  "maxAge": 1,
  "address1": "400 Burrard Street",
  "industry": "",
  "address2": "Suite 1780",
  "previousClose": 0.073547,
  "regularMarketOpen": 0.075946,
  "twoHundredDayAverage": 0.13031022,
  "trailingAnnualDividendYield": null,
  "payoutRatio": null,
  "volume24Hr": null,
  "regularMarketDayHigh": 0.073547,
  "navPrice": null,
  "averageDailyVolume10Day": 3312,
  "totalAssets": null,
  "regularMarketPreviousClose": 0.073547,
  "fiftyDayAverage": 0.109290004,
  "trailingAnnualDividendRate": null,
  "open": 0.075946,
  "averageVolume10days": 3312,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": 1.397359,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 0.073547,
  "priceHint": 4,
  "currency": "USD",
  "regularMarketVolume": 16499,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 3632111,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 1230,
  "priceToSalesTrailing12Months": null,
  "dayLow": 0.073547,
  "ask": 0,
  "ytdReturn": null,
  "askSize": 0,
  "volume": 16499,
  "fiftyTwoWeekHigh": 0.29,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 0.05386,
  "bid": 0,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": 0,
  "dayHigh": 0.073547,
  "exchange": "PNK",
  "shortName": "PASCAL BIOSCIENCES INC",
  "longName": "Pascal Biosciences Inc.",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "BIMUF",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_169985712",
  "uuid": "cc1728f1-eaea-346e-aa65-54bce8fbac8f",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": 0,
  "enterpriseToEbitda": null,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 52547400,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": 0.072,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1575072000,
  "heldPercentInstitutions": 0,
  "netIncomeToCommon": null,
  "trailingEps": -0.032,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": 1.0214862,
  "heldPercentInsiders": 0.036510002,
  "nextFiscalYearEnd": 1638230400,
  "mostRecentQuarter": 1598832000,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 53448445,
  "enterpriseValue": 4151062,
  "threeYearAverageReturn": null,
  "lastSplitDate": null,
  "lastSplitFactor": null,
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 0.075946,
  "logo_url": "https://logo.clearbit.com/pascalbiosciences.com"
}